Avinash Kali1, Ivan Cokic1, Richard Tang1, Alice Dohnalkova1, Libor Kovarik1, Hsin-Jung Yang1, Andreas Kumar1, Frank S Prato1, John C Wood1, David Underhill1, Eduardo Marbán1, Rohan Dharmakumar2. 1. From the Cedars-Sinai Medical Center, Los Angeles, CA (A.K., I.C., R.T., H.-J.Y., A.K., D.U., E.M., R.D.); University of California, Los Angeles (A.K., H.-J.Y., D.U., E.M., R.D.); Pacific Northwest National Laboratory, Environmental Molecular Sciences Laboratory, Richland, WA (A.D., L.K.); Lawson Health Research Institute, University of Western Ontario, London, Canada (F.S.P.); and Children's Hospital Los Angeles, CA (J.C.W.). 2. From the Cedars-Sinai Medical Center, Los Angeles, CA (A.K., I.C., R.T., H.-J.Y., A.K., D.U., E.M., R.D.); University of California, Los Angeles (A.K., H.-J.Y., D.U., E.M., R.D.); Pacific Northwest National Laboratory, Environmental Molecular Sciences Laboratory, Richland, WA (A.D., L.K.); Lawson Health Research Institute, University of Western Ontario, London, Canada (F.S.P.); and Children's Hospital Los Angeles, CA (J.C.W.). rohandkumar@csmc.edu.
Abstract
BACKGROUND: Emerging evidence indicates that persistent microvascular obstruction (PMO) is more predictive of major adverse cardiovascular events than myocardial infarct (MI) size. But it remains unclear how PMO, a phenomenon limited to the acute/subacute period of MI, drives adverse remodeling in chronic MI setting. We hypothesized that PMO resolves into chronic iron crystals within MI territories, which in turn are proinflammatory and favor adverse remodeling post-MI. METHODS AND RESULTS: Canines (n=40) were studied with cardiac magnetic resonance imaging to characterize the spatiotemporal relationships among PMO, iron deposition, infarct resorption, and left ventricular remodeling between day 7 (acute) and week 8 (chronic) post-MI. Histology was used to assess iron deposition and to examine relationships between iron content with macrophage infiltration, proinflammatory cytokine synthesis, and matrix metalloproteinase activation. Atomic resolution transmission electron microscopy was used to determine iron crystallinity, and energy-dispersive X-ray spectroscopy was used to identify the chemical composition of the iron composite. PMO with or without reperfusion hemorrhage led to chronic iron deposition, and the extent of this deposition was strongly related to PMO volume (r>0.8). Iron deposits were found within macrophages as aggregates of nanocrystals (≈2.5 nm diameter) in the ferric state. Extent of iron deposits was strongly correlated with proinflammatory burden, collagen-degrading enzyme activity, infarct resorption, and adverse structural remodeling (r>0.5). CONCLUSIONS: Crystallized iron deposition from PMO is directly related to proinflammatory burden, infarct resorption, and adverse left ventricular remodeling in the chronic phase of MI in canines. Therapeutic strategies to combat adverse remodeling could potentially benefit from taking into account the chronic iron-driven inflammatory process.
BACKGROUND: Emerging evidence indicates that persistent microvascular obstruction (PMO) is more predictive of major adverse cardiovascular events than myocardial infarct (MI) size. But it remains unclear how PMO, a phenomenon limited to the acute/subacute period of MI, drives adverse remodeling in chronic MI setting. We hypothesized that PMO resolves into chronic iron crystals within MI territories, which in turn are proinflammatory and favor adverse remodeling post-MI. METHODS AND RESULTS:Canines (n=40) were studied with cardiac magnetic resonance imaging to characterize the spatiotemporal relationships among PMO, iron deposition, infarct resorption, and left ventricular remodeling between day 7 (acute) and week 8 (chronic) post-MI. Histology was used to assess iron deposition and to examine relationships between iron content with macrophage infiltration, proinflammatory cytokine synthesis, and matrix metalloproteinase activation. Atomic resolution transmission electron microscopy was used to determine iron crystallinity, and energy-dispersive X-ray spectroscopy was used to identify the chemical composition of the iron composite. PMO with or without reperfusion hemorrhage led to chronic iron deposition, and the extent of this deposition was strongly related to PMO volume (r>0.8). Iron deposits were found within macrophages as aggregates of nanocrystals (≈2.5 nm diameter) in the ferric state. Extent of iron deposits was strongly correlated with proinflammatory burden, collagen-degrading enzyme activity, infarct resorption, and adverse structural remodeling (r>0.5). CONCLUSIONS: Crystallized iron deposition from PMO is directly related to proinflammatory burden, infarct resorption, and adverse left ventricular remodeling in the chronic phase of MI in canines. Therapeutic strategies to combat adverse remodeling could potentially benefit from taking into account the chronic iron-driven inflammatory process.
Authors: A Scaccabarozzi; P Arosio; G Weiss; L Valenti; P Dongiovanni; A L Fracanzani; M Mattioli; S Levi; G Fiorelli; S Fargion Journal: Br J Haematol Date: 2000-09 Impact factor: 6.998
Authors: A Ducharme; S Frantz; M Aikawa; E Rabkin; M Lindsey; L E Rohde; F J Schoen; R A Kelly; Z Werb; P Libby; R T Lee Journal: J Clin Invest Date: 2000-07 Impact factor: 14.808
Authors: William Chan; Andrew J Taylor; Andris H Ellims; Lisa Lefkovits; Chiew Wong; Bronwyn A Kingwell; Alaina Natoli; Kevin D Croft; Trevor Mori; David M Kaye; Anthony M Dart; Stephen J Duffy Journal: Circ Cardiovasc Interv Date: 2012-04-10 Impact factor: 6.546
Authors: Marcin Dobaczewski; Ying Xia; Marcin Bujak; Carlos Gonzalez-Quesada; Nikolaos G Frangogiannis Journal: Am J Pathol Date: 2010-04-09 Impact factor: 4.307
Authors: Lourens F H J Robbers; Elise S Eerenberg; Paul F A Teunissen; Matthijs F Jansen; Maurits R Hollander; Anton J G Horrevoets; Paul Knaapen; Robin Nijveldt; Martijn W Heymans; Marcel M Levi; Albert C van Rossum; Hans W M Niessen; C Bogdan Marcu; Aernout M Beek; Niels van Royen Journal: Eur Heart J Date: 2013-04-17 Impact factor: 29.983
Authors: Javier Ganame; Giancarlo Messalli; Steven Dymarkowski; Frank E Rademakers; Walter Desmet; Frans Van de Werf; Jan Bogaert Journal: Eur Heart J Date: 2009-04-03 Impact factor: 29.983
Authors: Matthew DeBerge; Shuang Zhang; Kristofor Glinton; Luba Grigoryeva; Islam Hussein; Esther Vorovich; Karen Ho; Xunrong Luo; Edward B Thorp Journal: Front Immunol Date: 2017-11-01 Impact factor: 7.561
Authors: Borja Ibanez; Anthony H Aletras; Andrew E Arai; Hakan Arheden; Jeroen Bax; Colin Berry; Chiara Bucciarelli-Ducci; Pierre Croisille; Erica Dall'Armellina; Rohan Dharmakumar; Ingo Eitel; Rodrigo Fernández-Jiménez; Matthias G Friedrich; David García-Dorado; Derek J Hausenloy; Raymond J Kim; Sebastian Kozerke; Christopher M Kramer; Michael Salerno; Javier Sánchez-González; Javier Sanz; Valentin Fuster Journal: J Am Coll Cardiol Date: 2019-07-16 Impact factor: 24.094
Authors: Thomas Bochaton; Jules Lassus; Alexandre Paccalet; François Derimay; Gilles Rioufol; Cyril Prieur; Eric Bonnefoy-Cudraz; Claire Crola Da Silva; Hugo Bernelin; Camille Amaz; Sylvie Espanet; Charles de Bourguignon; Nathalie Dufay; Régine Cartier; Pierre Croisille; Michel Ovize; Nathan Mewton Journal: PLoS One Date: 2021-01-28 Impact factor: 3.240
Authors: Jaclyn Carberry; David Carrick; Caroline Haig; Nadeem Ahmed; Ify Mordi; Margaret McEntegart; Mark C Petrie; Hany Eteiba; Stuart Hood; Stuart Watkins; Mitchell Lindsay; Andrew Davie; Ahmed Mahrous; Ian Ford; Naveed Sattar; Paul Welsh; Aleksandra Radjenovic; Keith G Oldroyd; Colin Berry Journal: JACC Cardiovasc Imaging Date: 2017-11-15